Radiation risk of screening-detected diffuse goiter in a Belarusian cohort exposed as children or adolescents to iodine-131 after Chernobyl
BACKGROUND: We previously reported a significantly increased risk of thyroid cancer due to radioactive iodine-131 (131I) after the 1986 Chernobyl nuclear accident in a cohort of children and adolescents from Belarus. Radiation-related cancer risks were five times higher among those with diffuse goiter, but the relationship between radiation dose and diffuse goiter is not well understood. METHODS: We used logistic regression to analyze data from 10,278 study participants (mean thyroid dose=0.63 gray (Gy)) who were screened 10-15 years after exposure according to a standardized protocol, which specified thyroid size assessment by both ultrasound and palpation. RESULTS: Diffuse goiter was identified in 1,811 subjects and was significantly associated with 131I dose (P<0.001). The linear model provided the best fit to the data at doses <0.5 Gy (excess odds ratio per gray (EOR/Gy) = 1.45, 95% confidence interval (CI): 0.70, 2.41) and linear-exponential model at doses <1.5 Gy (odds ratio (OR) at 1 Gy = 1.84). Age at exposure and indicators of iodine deficiency both before the accident (place of residence) and during screening (urinary iodine levels) significantly modified the dose-response (all P-values < 0.01). CONCLUSIONS: The first systematic evaluation of radiation risks of diffuse goiter after environmental exposure found a strong, statistically significant association with thyroid dose. IMPACT: Our study shows that radiation exposure is associated with a significantly increased risk of developing diffuse goiter. Future epidemiological studies of iodine-deficient irradiated populations should assess thyroid size.
Authors
- Minenko Vf
- Alina V. Brenner (ORCID: https://orcid.org/0000-0002-8556-3907)
- Lydia B. Zablotska (ORCID: https://orcid.org/0000-0002-0778-1108)
- Kiyóhiko Mabuchi (ORCID: https://orcid.org/0000-0002-8867-8777)
- Maureen Hatch (ORCID: https://orcid.org/0000-0001-9209-1269)
- Elizabeth K. Cahoon (ORCID: https://orcid.org/0000-0002-8028-0588)
- A. V. Razhko (ORCID: https://orcid.org/0000-0001-9965-8424)
- Vasilina Yauseyenka (ORCID: https://orcid.org/0000-0002-3101-5593)
- Robert McConnell (ORCID: https://orcid.org/0000-0002-9565-9574)
- Vladimir Drozdovitch (ORCID: https://orcid.org/0000-0002-7952-379X)
- Mark P. Little (ORCID: https://orcid.org/0000-0003-0980-7567)
- Patrick O’Kane (ORCID: https://orcid.org/0000-0001-5038-934X)
- Iryna A. Vasiukhina (ORCID: https://orcid.org/0009-0009-7587-3774)
- Olga V. Parhomenko (ORCID: https://orcid.org/0000-0001-9637-3941)
Institutions
- Northwestern University (US)
- Thomas Jefferson University (US)
- University of California, San Francisco (US)
- Columbia University Irving Medical Center (US)
- Republican Research Center for Radiation Medicine and Human Ecology (BY)
- National Cancer Institute (MY)
- National Cancer Institute (US)
- National Cancer Research Institute (GB)
- University of San Francisco (US)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2026-06-16
- DOI
- https://doi.org/10.1158/1055-9965.epi-25-1949
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00